AAAAAA

   
Results: 1-19 |
Results: 19
Disseminated breast cancer cells prior to and after high-dose therapy
Authors: Kruger, WH Kroger, N Togel, F Renges, H Badbaran, A Hornung, R Jung, R Gutensohn, K Gieseking, F Janicke, F Zander, AR
Citation: Wh. Kruger et al., Disseminated breast cancer cells prior to and after high-dose therapy, J HEMATH ST, 10(5), 2001, pp. 681-689
Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoringhematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation
Authors: Fehse, B Chukhlovin, A Kuhlcke, K Marinetz, O Vorwig, O Renges, H Kruger, W Zabelina, T Dudina, O Finckenstein, FG Kroger, N Kabisch, H Hochhaus, A Zander, AR
Citation: B. Fehse et al., Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoringhematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation, J HEMATH ST, 10(3), 2001, pp. 419-425
Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells
Authors: Kruger, W Kroger, N Togel, F Badbaran, A Renges, H Gieseking, F Gutensohn, K Janicke, F Zander, AR
Citation: W. Kruger et al., Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells, J HEMATH ST, 10(2), 2001, pp. 303-307
Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells
Authors: Togel, F Datta, C Badbaran, A Kroger, N Renges, H Gieseking, F Janicke, F Zander, AR Kruger, W
Citation: F. Togel et al., Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells, J HEMATH ST, 10(1), 2001, pp. 141-145
Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells
Authors: Kruger, WH Jung, R Detlefsen, B Mumme, S Badbaran, A Brandner, J Renges, H Kroger, N Zander, AR
Citation: Wh. Kruger et al., Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells, MED ONCOL, 18(1), 2001, pp. 33-38
Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors
Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Durken, M von Finkenstein, FG Erttmann, R Kabisch, H Schafhausen, P Jaburg, N Loliger, C Zander, AR
Citation: N. Kroger et al., Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors, ANN HEMATOL, 80(4), 2001, pp. 209-215
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome
Authors: Kroger, N Schetelig, J Zabelina, T Kruger, W Renges, H Stute, N Schrum, J Kabisch, H Siegert, W Zander, AR
Citation: N. Kroger et al., A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome, BONE MAR TR, 28(7), 2001, pp. 643-647
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients
Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Kabisch, H Jaburg, N Loliger, C Krull, A Zander, AR
Citation: N. Kroger et al., Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients, BONE MAR TR, 27(4), 2001, pp. 349-354
Patient cytomegalovirus seropositivity with or without reactivation is themost important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin
Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Schrum, J Kabisch, H Schafhausen, P Jaburg, N Loliger, C Schafer, P Hinke, A Zander, AR
Citation: N. Kroger et al., Patient cytomegalovirus seropositivity with or without reactivation is themost important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin, BR J HAEM, 113(4), 2001, pp. 1060-1071
Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma
Authors: Kroger, N Kruger, W Renges, H Zabelina, T Stute, N Jung, R Wittkowsky, G Kuse, R Zander, AR
Citation: N. Kroger et al., Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma, BR J HAEM, 112(2), 2001, pp. 421-423
Comparison of progenitor cell collection on day 4 or day 5 after steady-state stimulation with G-CSF alone in breast cancer patients: Influence on CD34(+) cell yield, subpopulation, and breast cancer cell contamination
Authors: Kroger, N Kruger, W Renges, H Zeller, W Rauhoft, C Loliger, C Zander, AR
Citation: N. Kroger et al., Comparison of progenitor cell collection on day 4 or day 5 after steady-state stimulation with G-CSF alone in breast cancer patients: Influence on CD34(+) cell yield, subpopulation, and breast cancer cell contamination, J HEMATH ST, 9(1), 2000, pp. 111-117
Allogeneic bone marrow transplantation for refractory mantle cell lymphoma
Authors: Kroger, N Hoffknecht, M Kruger, W Zeller, W Renges, H Stute, N Zschaber, R Zander, AR
Citation: N. Kroger et al., Allogeneic bone marrow transplantation for refractory mantle cell lymphoma, ANN HEMATOL, 79(10), 2000, pp. 578-580
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia
Authors: Kroger, N Zabelina, T Sonnenberg, S Kruger, W Renges, H Stute, N Finkenstein, F Mayer, U Holstein, K Fiedler, W Colberg, H Sonnen, R Kuse, R Braumann, D Metzner, B del Valle, F Erttmann, R Kabisch, H Zander, AR
Citation: N. Kroger et al., Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia, BONE MAR TR, 26(7), 2000, pp. 711-716
A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization inhealthy donors for allogeneic transplantation
Authors: Kroger, N Renges, H Kruger, W Gutensohn, K Loliger, C Carrero, I Cortes, L Zander, AR
Citation: N. Kroger et al., A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization inhealthy donors for allogeneic transplantation, BR J HAEM, 111(3), 2000, pp. 761-765
Steady-state mobilization of peripheral blood progenitor cells by cytokines alone in patients with solid tumors or hematological malignancies
Authors: Kroger, N Zeller, W Hassan, HT Kruger, W Renges, H Russmann, B Fuchs, N Rauhoft, C Gutensohn, K Loliger, C Erttmann, R Kuhnl, P Zander, AR
Citation: N. Kroger et al., Steady-state mobilization of peripheral blood progenitor cells by cytokines alone in patients with solid tumors or hematological malignancies, INFUSIONSTH, 26(2), 1999, pp. 85-90
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow
Authors: Zander, AR Zabelina, T Kroger, N Renges, H Kruger, W Loliger, C Durken, M Stockschlader, M de Wit, M Wacker-Backhaus, G Bielack, S Jaburg, N Russmann, B Erttmann, R Kabisch, H
Citation: Ar. Zander et al., Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, BONE MAR TR, 23(9), 1999, pp. 889-893
Efficacy of further attempts to mobilize CD34+peripheral stem cells with alternative procedures after primary failure
Authors: Kroger, N Rauhoft, C Zeller, W Renges, H Hassan, HT Kruger, W Schuch, G Wacker-Backhaus, G Colberg, H Kuse, R Gutensohn, K Loliger, C Zander, AR
Citation: N. Kroger et al., Efficacy of further attempts to mobilize CD34+peripheral stem cells with alternative procedures after primary failure, ACT HAEMAT, 102(3), 1999, pp. 144-147
Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B
Authors: Kruger, WH Kroger, N Russmann, B Renges, H Kabisch, H Zander, AR
Citation: Wh. Kruger et al., Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B, BONE MAR TR, 22, 1998, pp. S10-S13
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Authors: Kroger, N Kruger, W Wacker-Backhaus, G Hegewisch-Becker, S Stockschlader, M Fuchs, N Russmann, B Renges, H Durken, M Bielack, S de Wit, M Schuch, G Bartels, H Braumann, D Kuse, R Kabisch, H Erttmann, R Zander, AR
Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033
Risultati: 1-19 |